CDL Condition Clinical Entry Criteria / Information required
• Dx required by specialist physician, paediatrician or endocrinologist, or state hospital provider
• All other disciplines, to submit pathology confirming the diagnosis
• Spirometric demonstration of at least partially reversible airflow obstruction (adults and children > 5 years)
• Changes in peakflow in response to a B2-agonist
• Diagnosis to be confirmed by a psychiatrist
• the primary psychiatric diagnosis/condition
• co-morbid psychiatric conditions contributing
• any other medically contributing conditions
• Psycho-social (e.g. drug and alcohol abuse, environmental factors etc.)
• Anti-microbial agents subject to culture and sensitivity/ antibiograms, excluding macrolides which are added as part of treatment of
• NYHA stage (if available) and/or Ejection Fraction (echocardiogram results)
• Sub-type must be specified - Dilated Congestive, Hypertrophic or Restrictive type
• NYHA stage (if available) and/or Ejection Fraction (echocardiogram results)
• Spirometric tests results - GOLD guidelines applied
• Clinical risk profile (e.g. smoking and exacerbation history)
• Antibiogram for non-first line antibiotics or history of use
CDL Condition Clinical Entry Criteria / Information required
• ICD-10 code and specialist physician (or nephrologist) Rx required
• submit FBC and phosphate levels for consideration for EPO
*If the patient's age, body weight and serum creatinine are known, the creatinine clearance can be calculated as follows:
Clcreat = (140 - age [yr]) x body wt [kg])
• Angina pectoris with supportive findings on ECG (exercise or stress), Duke Treadmill test, echocardiography or angiography
• Evidence of Acute Coronary Syndrome (date and type of event: acute MI, subsequent MI, coronary angioplasty, unstable angina, stent insertion,
• Lipogram or Total choloesterol (not finger prick blood test)
• Dx required by specialist physician, paediatrician, surgeon, gastroenterologist, or state hospital provider
• Dx required by specialist physician, paediatrician, neurosurgeon, neurologist, endocrinologist, or state hospital
• If age of onset is <16 y and insulin only - Dx accepted from Dr or pharmacy
• If age of onset is ≥ 16y - in both symptomatic and asymptomatic patients the diagnosis is based on the following
• plasma venous blood values (not fingerprick) values:
• Random blood glucose, fasting blood glucose at initiation; HbA1c needed six(6) monthly thereafter
• Patient must need insulin only (not on oral treatment at all)
• If patient starts with a sulphonylurea (SU) only - Dx accepted from Dr or pharmacy
• If patient starts with metformin (MET), glitazone (TZD), gliptin (DPP4-I) or any other Tx* - in both symptomatic and asymtomatic patients the
diagnosis is based on the following plasma venous blood (not fingerprick) values:
• Random blood glucose, fasting blood glucose at initiation; HbA1c needed six(6) monthly thereafter
• In cases where the patient is already on therapy (and hence RBG or FBG not available), due to diagnosis long ago, the HbA1c may be accepted for
* To exclude cases where these drugs are used for glucose intolerance, metabolic syndrome, insulin resistance or PCOD, but patient does not have
• ECG results to be submitted by the treating doctor
CDL Condition Clinical Entry Criteria / Information required
• Complete clinical history of the seizures; EEG tests results if available or where clinical history is not clear
• If history of Bipolar, Schizophrenia, Depression, Neuropathy or Migraine authorisations and/or claims for drugs for these conditions:
EEG/specialist report, or neurologist to confirm Dx telephonically
• Laboratory report showing Factor VIII and IX levels
• Haematologist, physician's or state hospital Rx required
• The South African Antiretroviral Treatment Guidelines 2013, Version 14 March 2013, apply
• Details of any symptomatic atherosclerotic disease and CV events, such as:
• Occlusion/stenosis of peripheral arteries; severity classification of PAD
• Blood pressure readings: at least 2 readings on different dates (at least 3/12 apart), unless BP is >180/110 or patient is at very high risk (see 3rd
bullet), in which case one BP reading is sufficient
• Clinical risk profile (information on associated CV conditions such as CAD, Diabetes, Heart failure, CKD, Stroke, PVD, Retinopathy, Chronic Kidney
Disease - if patient is not yet registered for one or more of these)
• Baseline (pre-treatment) lab report with TSH value required – patient only to be registered if TSH is above upper limit of normal (may vary from
• If patient is ≤ 50 years – Lab report showing LH, FSH, Oestradiol-17β and progesterone levels
• Dx required by specialist physician, neurologist, or state hospital provider
• EDSS and subtype of disease to be specified
• Dx required by specialist physician, neurologist, or state hospital provider
• The initial diagnosis may be confirmed by any registered doctor
• Access to second and third level items will require intervention by a neurologist or physician
CDL Condition Clinical Entry Criteria / Information required
• If no DMARDs: The initial diagnosis may be confirmed by any registered doctor, provided that the diagnosis is confirmed with diagnostic proof
• Access to second and third level items will require intervention by a specialist physician, paediatrician or a rheumatologist
• Dx required by psychiatrist, paediatric psychiatrist, or state hospital provider
• Dx required by specialist physician, paediatrician, rheumatologist, or state hospital provider
• Dx required by specialist physician, surgeon, gastroenterologist, or state hospital provider
Additional Chronic Clinical Entry Criteria / Information required Conditions
• Only funded on selective options from the chronic benefit
• Two reports from 2 independent clinicians, one of whom must be a child psychiatrist
• A teacher's report as well as the child psychiatrist report will be acceptable
• Only funded on selective options from the chronic benefit
• The diagnosis must clearly state all of the following:
• The primary psychiatric diagnosis/condition
• Co-morbid psychiatric conditions contributing
• Any other medically contributing conditions
• Pscyho-social (e.g. drug and alcohol abuse, environmental factors etc.)
• Additional clinical information required:
• HAM-D score must be submitted at initial diagnosis and thereafter on six(6) monthly follow up consultations
• Requests for continuation of second and third line therapy must be accompanied by HAM-D score every 3 to 6 months thereafter
• Only funded on selective options from the chronic benefit
• The diagnosis must be confirmed by a neurologist.
• Only funded on selective options from the chronic benefit
• The diagnosis must be confirmed by a dermatologist
Having a Psychic Home – Aspects of Identity Roger Kennedy The paper puts forward the notion of a psychic home as an organizing psychic structure central to the notion of personal identity. The psychic home consists of four elements – the internalization of a basic structure as a protected space for shelter, providing the core of the psychic home; the pre-established intersubjective symboli
ADDITION OF BEVACIZUMAB TO CAPECITABINE IMPROVES PROGRESSION-FREE SURVIVAL IN ELDERLY PATIENTS Key Points: • The addition of bevacizumab to capecitabine significantly prolonged progression-free survival in elderly patients with previously untreated metastatic colorectal cancer who were not considered candidates for oxaliplatin- or irinotecan-based chemotherapy. • No d